Phil Hahn

Senior Sales Representative @GSK

Bakersfield, CA, US

Senior Sales RepresentativeGSK | Jul 1990 – Present | Bakersfield, CAVaccine & Respiratory Franchise Leadership (2017–Present)- Promoted Trelegy, Shingrix, and Arexvy across pulmonary, primary care, and allergy- Ranked #1 in regional pulmonary share (47.5%),#1 in NRx share (36%), and consistently top 10% nationally (as high as 2.4%). Delivered 138+ in-services in 2024 and hosted multiple speaker programs- Broke access barriers at restricted institutions-Dignity Health-Recognition: Presidents club (2016,2017,2018,2019,2020,2022,2024)Respiratory & Biologics Growth (2010–2016)- Expanded into biologics with Nucala, Breo, Anoro, and early Trelegy positioning- Focused on payer navigation and patient access- Recognition: President’s Club (2010, 2016).Respiratory Specialty Expansion (2006–2009)- Promoted Advair, Flovent, Veramyst; selected as Regional Trainer to facilitate workshops across district/region- Recognition: President’s Club (2006, 2009).Neurology (1997–2006)- Promoted Imitrex and Amerge for migraine; expanded reach with Boniva in rheumatology and OB/GYN- Built referral networks and strengthened prescribing confidence.Hospital Specialty (1995–1997)- Hospital Division Rep at LAC/USC Medical Center. Promoted Lamictal, Zofran, neuromuscular blockers; successfully launched Retrovir (AZT) for HIV.Primary Care & Hospital Sales (1990–1994)- Promoted portfolio including Zovirax, Wellbutrin, Hytrin, Condylox, Digoxin, AZT, and anesthetics- Recognition: President’s Club (1991, 1994).Honors & Awards- President’s Club / Winner’s Circle (12×): 1991, 1994, 2006, 2009, 2010, 2016, 2017, 2018, 2019, 2020, 2022, 2024- Representative of the Year — West Coast Region (2024)- Kern NP & PA Association — Representative of the Year Leadership Training Program Graduate (2023)- Above & Beyond Recognitions- Trelegy National Advisory Board (2018–2025)- Regional Peer Educator (2018–2025)- Mentorship (2018–2025)